证券记录 · 已归档季度
HALO
Halozyme Therapeutics, Inc. · Healthcare · Biotechnology
14被追踪持有人
n/aΔ持有人
8.14M持有股份
$426.06M报告持仓市值
+0新建仓位
−0清仓
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 502.79K | $49.11M | n/a | n/a |
| Q2 2026 | 131 | -1 | 91.15M | $6.60B | +6 | −8 |
| Q1 2026 | 136 | +1 | 88.77M | $5.36B | +7 | −7 |
| Q4 2025 | 135 | -1 | 97.38M | $6.16B | +1 | −1 |
| Q3 2025 | 22 | +1 | 49.86M | $3.66B | +1 | −1 |
| Q2 2025 | 19 | 0 | 43.24M | $2.25B | n/a | n/a |
| Q1 2025 | 16 | -1 | 15.61M | $996.39M | n/a | −1 |
| Q4 2024 | 17 | +3 | 17.59M | $840.95M | +4 | −1 |
| Q3 2024 | 13 | -1 | 6.97M | $398.81M | n/a | −1 |
| Q2 2024 | 14 | n/a | 8.14M | $426.06M | n/a | n/a |
持有人 · Q2 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (被动) | 3.03M | n/a | $158.64M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 2 | T. Rowe Price ✦ | 1.30M | n/a | $68.16M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 3 | Norges Bank ✦ (被动) | 1.22M | n/a | $63.68M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 478.77K | n/a | $25.07M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 423.19K | n/a | $22.16M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 6 | Wellington Management ✦ | 397.78K | n/a | $20.83M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 7 | Renaissance Technologies ✦ | 377.58K | n/a | $19.77M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 347.70K | n/a | $18.21M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 9 | Fisher Asset Management ✦ | 303.28K | n/a | $15.88M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Arrowstreet Capital ✦ | 102.75K | n/a | $5.38M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 48.99K | n/a | $2.56M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 47.77K | n/a | $2.50M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 13 | Bridgewater Associates ✦ | 33.22K | n/a | $1.74M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Gotham Asset Management ✦ | 28.38K | n/a | $1.49M | 0.0% | n/c | 1 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 630 持有人, 119.44M 股份, $7.40B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 08
Torley Helen
Officer, Director · 200 股 · $22,102
Oct 08
Torley Helen
Officer, Director · 11.90K 股 · $1.31M
Oct 08
Torley Helen
Officer, Director · 3.09K 股 · $336,526
Oct 08
Torley Helen
Officer, Director · 4.81K 股 · $520,341
Oct 07
Torley Helen
Officer, Director · 8.60K 股 · $954,867
Oct 07
Torley Helen
Officer, Director · 200 股 · $22,739
Oct 07
Torley Helen
Officer, Director · 900 股 · $101,502
Oct 07
Torley Helen
Officer, Director · 10.30K 股 · $1.15M
Oct 06
Torley Helen
Officer, Director · 1.78K 股 · $197,245
Oct 06
Torley Helen
Officer, Director · 9.92K 股 · $1.09M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2024 ·
方法论 ·
通过API获取此数据